In vitro diagnostics (IVD) is a method of diagnostic test in an external environment outside human body. The global IVD market is expected to generate revenue of $74.65 billion by 2020, registering a CAGR of 5.34% during 2014-2020.

1. Global In Vitro Diagnostics (IVD) Market (Technique, Product,
Usability, Application, End User, and Geography) - Size, Share,
Global Trends, Company Profiles, Demand, Insights, Analysis,
Research, Report, Opportunities, Segmentation and Forecast,
2013 - 2020
Published: June 2014
Pages: 152
Contact Us: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Mail us: sales@reportsandintelligence.com
Detailed report at: http://www.reportsandintelligence.com/ivd-in-
vitro-diagnostics-market

2. In vitro diagnostics (IVD) is a method of diagnostic test in an external environment outside
human body. The global IVD market is expected to generate revenue of $74.65 billion by 2020,
registering a CAGR of 5.34% during 2014-2020. The report segments the IVD market into
techniques, usability, application, product type, geography and end users. In terms of
Geographical analysis, Asia Pacific is would grow exponentially and is expected to generate
maximum revenue during the estimated period due to rising awareness and healthcare
expenditure of the people.
Technological strides along with rising incidences of infectious & chronic diseases are the key
factors that drive the market growth. Further, Widespread healthcare awareness and its cost
effectiveness would boost the market growth. However, the strict governing policies and
reimbursement concerns are slowing down the overall market growth.
VD Techniques Market Analysis
The report segments the global IVD techniques market into clinical chemistry, immunoassays,
molecular diagnostics, point of care, coagulation, microbiology, hematology, and other clinical
techniques. Point of care generates maximum revenue, while molecular diagnostics is growing
at a fastest rate due to its capability to detect main cause of the disease efficiently.
IVD Product Type Market Analysis
The report divides the product type marker on the basis of instruments, data management
systems, reagents, and services. Instruments market has the largest market share followed by
reagents market due to its usability in numerous diagnostic equipments. Increase in the use of
diagnostic devices that require a reagent is the main factor that is driving the market growth.
IVD Usability Market Analysis
Usability segment is categorized as reusable and disposable IVD devices. At present, clinicians
and doctors favor disposable devices, to stay away from infections. However, reusable IVD
device generates maximum revenue on the IVD usability market. Reusable devices are more
cost effectiveness and hence, driving the usability market growth.
IVD Applications Market Analysis
In terms of application, the report segments the IVD market based on cancer/oncology,
diabetes, cardiology, nephrology, autoimmune diseases, drug testing, HIV/AIDS and others.
Infectious disease is expected to continue generating maximum revenue during the analyzed
period.
IVD End User Market Analysis

3. The end users segment of the global IVD market consist of laboratories, academics, hospitals,
point of care testing and others. Academic institutions give IVD trainings to the students.
Laboratories are the maximum revenue generator followed by point of care in the end user
market.
IVD Geography Market Analysis
The geographical analysis is based on regions such as Europe, Asia Pacific, North America, and
Rest of World. North America is the largest revenue generating region in all segments of global
IVD market, whereas Asia Pacific region is fastest growing region amongst the regions studied.
IVD Competitive Analysis
The investigation of main ten players in the worldwide business uncovers methodologies
embraced to keep up their position in the aggressive business environment. Vital research of
the top players uncovers that market players are embracing product dispatch as their key
formative technique in the business sector, as the business players are advancing novel items to
grow their product range. Acquisitions and endorsements are some extra procedures received
by the organizations in the business to upgrade their business and extend their span over the
globe.
IVD High Level Analysis
The business sector research gives an agreeable perspective of worldwide IVD market. Porter’s
five-force model aides in dissecting business sector players, new contestants in the business
and the novel methodologies applied by them. In the current business situation, IVD market has
moderate haggling force of supplier due to brand loyalty. Fluctuating product differentiation
would create moderate buyers bargaining. High entrance barriers lead to lower risk of new
contestants. Intersegment substitution prompts lower danger of Substitute. The quality chain
analysis uncovers the key mediators included in the production network. Crude material
suppliers, medicinal gadget makers, wholesalers, administration suppliers and end clients are
the different stakeholders included in the supply network of IVD business.
Purpose behind Study
IVD is the most old procedure for analysis of the infection. With increment in occurrences of
infectious and chronic diseases and rising health awareness amongst patients, the business is
seems to be growth optimistic in various regions. As there is a movement from traditional
gadgets to cutting edge analytical gadgets, IVD would turn out to be a lucrative market in
future.

4. KEY BENEFITS
 Assessments are made according to the current business scenario and the future market
trends are forecast for the period 2013-2020, with the base figures of the year 2013
 The analysis gives a wider view of the global market including its market trends, market
structure, limiting factors and opportunities for the market
 Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the
competitive sketch of the market, which would guide the market players to develop
strategies accordingly
 The value chain analysis provides a systematic study on the key intermediaries involved,
which would in turn help the stakeholders in the market to make appropriate strategies
 The advantages of the market are analyzed to help the stakeholders identify the
opportunistic areas in a comprehensive manner
KEY MARKET SEGMENTS
MARKET BY TECHNIQUES
 Immunoassays
 Clinical Chemistry
 Point Of Care
 Molecular Diagnostics
 Hematology
 Coagulation
 Microbiology
 Other clinical techniques
MARKET BY PRODUCT TYPE
 Instruments
 Reagents
 Data management systems
 Services
MARKET BY USABILITY
 Disposable
 Reusable

5. MARKET BY APPLICATIONS
 Infectious Diseases
 Diabetes
 Cancer/Oncology
 Cardiology
 Autoimmune Diseases
 Nephrology
 Drug Testing
 HIV/AIDS
 Others
MARKET BY END USER
 Hospitals
 Laboratories
 Academics
 Point of Care Testing
 Others
MARKET BY GEOGRAPHY
 North America
 Europe
 Asia Pacific
 Rest of World
Table of Content
CHAPTER 1. INTRODUCTION
1.1 Report descriptions
1.2 Key market segments
1.3 Research methodology
1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings

6. 3.2.1 Top impacting factors for the in vitro diagnostic market
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porter five forces model
3.3.1 Brand loyalty leads to moderate bargaining power of supplier
3.3.2 Varying product differentiation would lead to moderate bargaining power of buyers
3.3.3 Low threat from new entrants due to high entry barriers
3.3.4 Less intersegment substitution leads to lower threat Of substitute
3.3.5 Moderate competitive rivalry
3.4 Government regulations
3.5 Value chain analysis
3.6 Case studies
3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system
3.7 Key technology trends
3.7.1 Medical automation technologies
3.7.2 Emerging markets in digital pathology
3.7.3 Omics and IVD
3.7.4 Genetics tests and IVD
3.7.5 Point of care testing:
3.7.6 Personalized medicine propelling growth:
3.7.7 Emerging diagnostic technologies and impact on IVD
3.8 Market dynamics
3.8.1 Drivers
3.8.1.1 Increasing incidences of chronic and infectious diseases
3.8.1.2 Technological advancements in IVD
3.8.1.3 Emergence of minimal invasive technologies
3.8.1.4 Increasing government expenditures on healthcare
3.8.1.5 Increase in popularity personalized medicine approach
3.8.2 Restraints
3.8.2.1 Unclear reimbursement policies
3.8.2.2 Stringent Regulatory policies
3.8.3 Opportunities
3.8.3.1 Potential Opportunities for outsourcing
3.8.3.2 Convergence of new Technologies.
CHAPTER 4. GLOBAL IVD MARKET BY TECHNIQUES
4.1 Immunoassay/Immunochemistry
4.2 Hematology
4.2.1 High throughput analyzer
4.2.2 Medium throughput analyzer
4.2.3 Low throughput analyzer
4.3 Clinical chemistry
4.3.1 Urine chemistry analyzers

7. 4.3.2 Blood gas electrolyte analyzers
4.3.3 Others
4.4 Coagulation
4.5 Microbiology
4.5.1 Blood culture
4.5.2 Pathological culture
4.5.3 Identification & antibiotic susceptibility testing
4.5.4 Others
4.6 Molecular diagnostics
4.6.1 Infectious diseases
4.6.2 Oncology
4.6.3 Genetic diseases
4.6.4 Blood screening
4.6.5 Others
4.7 Point of care
4.8 Other clinical techniques
4.8.1 Clinical centrifuges
4.8.2 Tissue diagnosis
4.8.3 Sample processors
4.8.4 Flow cytometry
4.8.5 Cytology
CHAPTER 5. GLOBAL IVD MARKET BY PRODUCT TYPE
5.1 Instruments
5.2 Reagents
5.3 Data management system hardware/software
5.4 Services
CHAPTER 6. GLOBAL IVD MARKET BY USABILITY
6.1 Disposable IVD devices
6.2 Re-Usable IVD devices
CHAPTER 7. GLOBAL IVD MARKET BY APPLICATION
7.1 Infectious diseases
7.2 Diabetes
7.3 Cancer/Oncology
7.4 Cardiology
7.5 Autoimmune diseases
7.6 Nephrology
7.7 Drug testing
7.8 HIV/AIDS
7.9 Others
CHAPTER 8. GLOBAL IVD MARKET BY END USERS

8. 8.1 Hospitals
8.2 Laboratory
8.3 Academics
8.4 Point-of-Care Testing
8.5 Others
CHAPTER 9. GLOBAL IVD MARKET BY GEOGRAPHY
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 RoW
CHAPTER 10. COMPANY PROFILES
10.1 Alere Inc
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Business performance
10.1.4 Key Strategies and developments
10.1.5 SWOT analysis of Alere
10.2 Biomerieux
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Business performance
10.2.4 Key Strategies and developments
10.2.4.1 Primary STRATEGIES: APPROVAL
10.2.4.2 Secondary strategies: Acquisition
10.2.5 SWOT analysis of BioMerieux
10.3 Danaher Corporation.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Business performance
10.3.4 Key Strategies and development
10.3.5 SWOT analysis of Danaher
10.4 Roche Diagnostics.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Business performance
10.4.4 Key Strategies and developments
10.4.5 SWOT analysis of Roche
10.5 Becton Dickinson And Company
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Business performance
10.5.4 Key Strategies and development

9. 10.5.4.1 Primary strategies: product launch
10.5.4.2 Secondary strategies: Acquisition and Approval
10.5.5 SWOT analysis of Becton Dickinson and Company
10.6 Bio-Rad Laboratories
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Business performance
10.6.4 Key Strategies and developments
10.6.5 SWOT analysis of Bio-Rad Laboratories
10.7 Abbott Laboratories
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Business Performance
10.7.4 Key Strategies and developments
10.7.5 SWOT analysis of Abbott Laboratories
10.8 Bayer AG.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Business Performance
10.8.4 Key Strategies and Development
10.8.5 SWOT analysis of Bayer AG
10.9 Arkray Inc.
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Key Strategies and development
10.9.3.1 Primary strategies
10.9.3.2 Secondary strategies
10.9.4 SWOT analysis of Arkray
10.10 Sysmex
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Business performance
10.10.4 Key strategies and developments
10.10.4.1 Primary strategies: partnership
10.10.4.2 Secondary strategies: approval
10.10.5 SWOT analysis of Sysmex
10.11 Johnson & Johnson
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Business Performance
10.11.4 Key Strategies and Development
10.11.4.1 Primary strategies: partnership
10.11.4.2 Secondary strategies
10.11.5 SWOT analysis of Johnson & Johnson

10. 10.12 Siemens
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Business performance
10.12.4 Key Strategies and development
10.12.5 SWOT analysis of Siemens
LIST OF TABLES
TABLE 1 IVD MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 2 PORTERS FIVE FORCES MODEL
TABLE 3 GLOBAL INCIDENCES OF DISEASES
TABLE 4 GLOBAL IVD MARKET BY TECHNIQUE, 2013-2020 ($BILLION)
TABLE 5 GLOBAL IMMUNOASSAY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 6 GLOBAL HEMATOLOGY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 7 GLOBAL CLINICAL CHEMISTRY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020
($BILLION)
TABLE 8 GLOBAL COAGULATION TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 9 GLOBAL MICROBIOLOGY TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS TECHNIQUE MARKET BY GEOGRAPHY, 2013-2020
($BILLION)
TABLE 11 POINT OF CARE TECHNIQUE MARKET,2013-2020,($BILLION)
TABLE 12 GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY, 2013.-.2020, -.($BILLION)
TABLE 13 GLOBAL IVD BY PRODUCT TYPE MARKET, 2013-2020 ($BILLION)
TABLE 14 GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 15 GLOBAL REAGENTS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 16 GLOBAL DATA MANAGEMENT SOFTWARE MARKET BY GEOGRAPHY, 2013-2020
($BILLION)
TABLE 17 GLOBAL SERVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 18 GLOBAL IVD USABILITY MARKET, 2013-2020 ($BILLION)
TABLE 19 GLOBAL IVD DISPOSABLE DEVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 20 GLOBAL IVD REUSABLE DEVICES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 21 LIST OF MANUFACTURERS WITH RE-USABLE IVD DEVICES
TABLE 22 GLOBAL IVD APPLICATIONS MARKET, 2013-2020 ($BILLION)
TABLE 23 GLOBAL IVD INFECTIOUS DISEASES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 24 GLOBAL IVD DIABETES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 25 GLOBAL IVD CANCER/ONCOLOGY MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 26 GLOBAL IVD CARDIOLOGY MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 27 GLOBAL IVD AUTOIMMUNE DISEASES MARKET BY GEOGRAPHY, 2013-2020
($BILLIONS)
TABLE 28 GLOBAL IVD NEPHROLOGY MARKET BY GEOGRAPHY, 2013-2020,- ($BILLIONS)
TABLE 29 GLOBAL IVD DRUG TESTING MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 30 GLOBAL IVD HIV/AIDS MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 31 GLOBAL IVD OTHER DISEASES MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 32 GLOBAL IVD MARKET BY END USER ,2013-2020,($BILLION)

11. TABLE 33 GLOBAL IVD HOSPITALS MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 34 GLOBAL IVD LABORATORY MARKET BY GEOGRAPHY,2013-2020,($BILLIONS)
TABLE 35 GLOBAL IVD ACADEMICS MARKET BY GEOGRAPHY, 2013- 2020 ($BILLIONS)
TABLE 36 GLOBAL IVD POINT OF CARE TESTING MARKET BY GEOGRAPHY, 2013-2020
($BILLIONS)
TABLE 37 GLOBAL IVD OTHER MARKET BY GEOGRAPHY, 2013-2020 ($BILLIONS)
TABLE 38 GLOBAL IVD MARKET BY GEOGRAPHY, 2013-2020 ($BILLION)
TABLE 39 GLOBAL IVD NORTH AMERICA MARKET, 2013-2020 ($BILLION)
TABLE 40 GLOBAL IVD EUROPE MARKET, 2013-2020 ($BILLION)
TABLE 41 GLOBAL IVD ASIA PACIFIC MARKET, 2013-2020 ($BILLION)
TABLE 42 GLOBAL IVD REST OF THE WORLD MARKET, 2013-2020 ($BILLION)
TABLE 43 ALERE COMPANY SNAPSHOT
TABLE 44 BIOMERIEUX COMPANY SNAPSHOT
TABLE 45 DANAHER COMPANY SNAPSHOT
TABLE 46 ROCHE COMPANY SNAPSHOT
TABLE 47 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 48 BIO-RAD LABORATORIES SNAPSHOT
TABLE 49 ABBOTT LABORATORIES SNAPSHOT
TABLE 50 BAYER AG COMPANY SNAPSHOT
TABLE 51 ARKRAY COMPANY SNAPSHOT
TABLE 52 SYSMEX COMPANY SNAPSHOT
TABLE 53 JOHNSON & JOHNSON COMPANY SNAPSHOT
TABLE 54 SIEMENS COMPANY SNAPSHOT
LIST OF FIGURES
FIG. 1 TOP IMPACTING FACTORS
FIG. 2 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2013-2020.
FIG. 3 TOP WINNING STRATEGIES
FIG. 4 TOP WINNING STRATEGIES
FIG. 5 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 6 KEY FINANCIALS OF ALERE BY SALES 2013
FIG. 7 KEY FINANCIALS OF NET REVENUE BY GEOGRAPHY 2013
FIG. 8 SWOT ANALYSIS OF ALERE
FIG. 9 KEY FINANCIALS OF BREAKDOWN OF SALES BY TECHNOLOGY
FIG. 10 KEY FINANCIALS OF BREAKDOWN OF SALES BY GEOGRAPHY
FIG. 11 SWOT ANALYSIS OF BIOMERIEUX
FIG. 12 KEY FINANCIALS OF DANAHER SALES BY SEGMENT 2013
FIG. 13 KEY FINANCIALS OF DANAHER SALES BY GEOGRAPHY 2013
FIG. 14 SWOT ANALYSIS OF DANAHER
FIG. 15 KEY FINANCIALS OF ROCHE REVENUES BY SEGMENT 2012
FIG. 16 KEY FINANCIALS OF ROCHE SALES BY GEOGRAPHY 2013
FIG. 17 SWOT ANALYSIS OF ROCHE
FIG. 18 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2013
FIG. 19 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2013

12. FIG. 20 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 21 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUES BY SEGMENT 2013
FIG. 22 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUES BY GEOGRAPHY 2013
FIG. 23 SWOT ANALYSIS OF BIO-RAD LABORATORIES
FIG. 24 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUES BY SEGMENT 2013
FIG. 25 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUES BY GEOGRAPHY 2013
FIG. 26 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 27 KEY FINANCIALS OF BAYER AG COMPANY REVENUES BY SEGMENT 2013
FIG. 28 SWOT ANALYSIS OF BAYER AG
FIG. 29 SWOT ANALYSIS OF ARKRAY
FIG. 30 KEY FINANCIALS OF SYSMEX COMPANY REVENUES BY SEGMENT 2013
FIG. 31 KEY FINANCIALS OF SYSMEX COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 32 SWOT ANALYSIS OF SYSMEX
FIG. 33 KEY FINANCIALS OF JOHNSON & JOHNSON COMPANY REVENUES BY SEGMENT 2013
FIG. 34 KEY FINANCIALS OF JOHNSON & JOHNSON COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 35 SWOT ANALYSIS OF JOHNSON & JOHNSON
FIG. 36 KEY FINANCIALS OF SIEMENS COMPANY REVENUES BY SEGMENT 2013
FIG. 37 KEY FINANCIALS OF SIEMENS COMPANY REVENUES BY GEOGRAPHY 2013
FIG. 38 SWOT ANALYSIS OF SIEMENS
Contact Us:
Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555 (U.S. & Canada)
Fax: +1 (855) 550-5975
Email: sales@analyzefuture.com
Web: http://www.analyzefuture.com